Histone methyltransferases: Opportunities in cancer drug discovery

Epigenetic Therapy of Cancer: Preclinical Models and Treatment Approaches

Volumn , Issue , 2013, Pages 189-226

  Chesworth, Richard ^a   Wigle, Tim J ^a   Kuntz, Kevin W ^a   Smith, Jesse J ^a   Richon, Victoria M ^a  

^a Department of Molecular Discovery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929535203     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-38404-2_9     Document Type: Chapter

References (184)

1. Abu-Farha M et al (2008) The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase. Mol Cell Proteomics 7(3):560-572
2. Adams-Cioaba MA, Min J (2009) Structure and function of histone methylation binding proteins. Biochem Cell Biol 87(1):93-105
3. Aggarwal P et al (2010) Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. Cancer Cell 18(4):329-340
4. Agger K et al (2007) UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449(7163):731-734
5. Allan M et al (2009) N-Benzyl-1-heteroaryl-3-(trifl uoromethyl)-1H-pyrazole-5-carboxamides as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1). Bioorg Med Chem Lett 19(4):1218-1223
6. Andreu-Vieyra CV et al (2010) MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing. PLoS Biol 8(8):e1000453
7. Angrand PO et al (2001) NSD3, a new SET domain-containing gene, maps to 8p12 and is ampli-fi ed in human breast cancer cell lines. Genomics 74(1):79-88
8. Barrett A et al (2007) Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases. Int J Cancer 121(2):265-275
9. Barry ER, Corry GN, Rasmussen TP (2010) Targeting DOT1L action and interactions in leukemia: the role of DOT1L in transformation and development. Expert Opin Ther Targets 14(4):405-418
10. Barski A et al (2007) High-resolution profi ling of histone methylations in the human genome. Cell 129(4):823-837
11. Bedford MT, Richard S (2005) Arginine methylation: an emerging regulator of protein function. Mol Cell 18:263-272
12. Bernstein BE et al (2005) Genomic maps and comparative analysis of histone modifi cations in human and mouse. Cell 120(2):169-181
13. Bernstein BE et al (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2):315-326
14. Bitoun E, Oliver PL, Davies KE (2007) The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet 16(1):92-106
15. Boisvert FM et al (2005a) Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control. Genes Dev 19(6):671-676
16. Boisvert FM et al (2005b) The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity. Cell Cycle 4(12):1834-1841
17. Botuyan MV et al (2006) Structural basis for the methylation state-specifi c recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell 127(7):1361-1373
18. Boyer LA et al (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122(6):947-956
19. Boyer LA et al (2006) Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441(7091):349-353
20. Bracken AP et al (2003) EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplifi ed in cancer. EMBO J 22(20):5323-5335
21. Brown MA et al (2006) Identifi cation and characterization of Smyd2: a split SET/MYND domaincontaining histone H3 lysine 36-specifi c methyltransferase that interacts with the Sin3 histone deacetylase complex. Mol Cancer 5:26
22. Cao R, Zhang Y (2004a) SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell 15(1):57-67
23. Cao R, Zhang Y (2004b) The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev 14(2):155-164
24. Cao R et al (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298(5595):1039-1043
25. Cao R et al (2008a) Role of hPHF1 in H3K27 methylation and Hox gene silencing. Mol Cell Biol 28(5):1862-1872
26. Cao Q et al (2008b) Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 27(58):7274-7284
27. Ceol CJ et al (2011) The histone methyltransferase SETDB1 is recurrently amplifi ed in melanoma and accelerates its onset. Nature 471(7339):513-517
28. Chang Y et al (2009) Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294. Nat Struct Mol Biol 16(3):312-317
29. Chang Y et al (2010) Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases. J Mol Biol 400(1):1-7
30. Chen D et al (1999) Regulation of transcription by a protein methyltransferase. Science 284(5423):2174-2177
31. Cheng X, Blumenthal RM (2010) Coordinated chromatin control: structural and functional linkage of DNA and histone methylation. Biochemistry 49(14):2999-3008
32. Chesi M et al (1998) The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 92(9):3025-3034
33. Cheung N et al (2007) Protein arginine-methyltransferase-dependent oncogenesis. Nat Cell Biol 9(10):1208-1215
34. Cloos PA et al (2006) The putative oncogene GASC1 demethylates tri-and dimethylated lysine 9 on histone H3. Nature 442(7100):307-311
35. Collins RE et al (2005) In vitro and in vivo analyses of a Phe/Tyr switch controlling product speci-fi city of histone lysine methyltransferases. J Biol Chem 280(7):5563-5570
36. Copeland RA, Solomon ME, Richon VM (2009) Protein methyltransferases as a target class for drug discovery. Nat Rev Drug Discov 8(9):724-732
37. Daigle SR et al (2011) Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell 20(1):53-65
38. Daujat S et al (2002) Crosstalk between CARM1 methylation and CBP acetylation on histone H3. Curr Biol 12(24):2090-2097
39. Del Rizzo PA et al (2010) SET7/9 catalytic mutants reveal the role of active site water molecules in lysine multiple methylation. J Biol Chem 285(41):31849-31858
40. Di Lorenzo A, Bedford MT (2011) Histone arginine methylation. FEBS Lett 585(13):2024-2031
41. Dillon SC et al (2005) The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol 6(8):227
42. Dirk LM et al (2007) Kinetic manifestation of processivity during multiple methylations catalyzed by SET domain protein methyltransferases. Biochemistry 46(12):3905-3915
43. Eissenberg JC, Shilatifard A (2010) Histone H3 lysine 4 (H3K4) methylation in development and differentiation. Dev Biol 339(2):240-249
44. El Messaoudi S et al (2006) Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene. Proc Natl Acad Sci USA 103(36):13351-13356
45. Feldman N et al (2006) G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol 8(2):188-194
46. Feng X, Hara Y, Riabowol K (2002) Different HATS of the ING1 gene family. Trends Cell Biol 12(11):532-538
47. Feng Q et al (2006) Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly. Mol Cell Biol 26(21):7846-7857
48. Fersht AR, Sperling J (1973) The charge relay system in chymotrypsin and chymotrypsinogen. J Mol Biol 74(2):137-149
49. Fraga MF et al (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37(4):391-400
50. Frietze S et al (2008) CARM1 regulates estrogen-stimulated breast cancer growth through upregulation of E2F1. Cancer Res 68(1):301-306
51. Frietze S et al (2010) ZNF274 recruits the histone methyltransferase SETDB1 to the 3 ends of ZNF genes. PLoS One 5(12):e15082
52. Gao WL, Liu HL (2007) DOT1: a distinct class of histone lysine methyltransferase. Yi Chuan 29(12):1449-1454
53. Guendel I et al (2010) Methylation of the tumor suppressor protein, BRCA1, infl uences its transcriptional cofactor function. PLoS One 5(6):e11379
54. Guo HB, Guo H (2007) Mechanism of histone methylation catalyzed by protein lysine methyltransferase SET7/9 and origin of product specifi city. Proc Natl Acad Sci USA 104(21):8797-8802
55. Guo Y et al (2009) Methylation-state-specifi c recognition of histones by the MBT repeat protein L3MBTL2. Nucleic Acids Res 37(7):2204-2210
56. Gupta RA et al (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464(7291):1071-1076
57. Hamamoto R et al (2004) SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol 6(8):731-740
58. Hamamoto R et al (2006) Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer Sci 97(2):113-118
59. Hess JL (2004) Mechanisms of transformation by MLL. Crit Rev Eukaryot Gene Expr 14(4):235-254
60. Higashimoto K et al (2007) Phosphorylation-mediated inactivation of coactivator-associated arginine methyltransferase 1. Proc Natl Acad Sci USA 104(30):12318-12323
61. Hong H et al (2004) Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status. Cancer 101(1):83-89
62. Horton JR et al (2010) Enzymatic and structural insights for substrate specifi city of a family of jumonji histone lysine demethylases. Nat Struct Mol Biol 17(1):38-43
63. Hou Z et al (2008) The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol Cell Biol 28(10):3198-3207
64. Huang Y et al (2009) Novel oligoamine analogues inhibit lysine-specifi c demethylase 1 and induce reexpression of epigenetically silenced genes. Clin Cancer Res 15(23):7217-7228
65. Huang J et al (2010) G9a and Glp methylate lysine 373 in the tumor suppressor p53. J Biol Chem 285(13):9636-9641
66. Huynh T et al (2009) Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1). Bioorg Med Chem Lett 19(11):2924-2927
67. Jaju RJ et al (2001) A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. Blood 98(4):1264-1267
68. Jansson M et al (2008) Arginine methylation regulates the p53 response. Nat Cell Biol 10(12):1431-1439
69. Jeong YS et al (2010) Phosphorylation of serine-10 of histone H3 shields modifi ed lysine-9 selectively during mitosis. Genes Cells 15(3):181-192
70. Kalakonda N et al (2008) Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1. Oncogene 27(31):4293-4304
71. Kang MY et al (2007) Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer. Int J Cancer 121(10):2192-2197
72. Kaustov L et al (2011) Recognition and specifi city determinants of the human cbx chromodomains. J Biol Chem 286(1):521-529
73. Kim H et al (2009) Requirement of histone methyltransferase SMYD3 for estrogen receptormediated transcription. J Biol Chem 284(30):19867-19877
74. Kireev D et al (2010) Identifi cation of non-peptide malignant brain tumor (MBT) repeat antagonists by virtual screening of commercially available compounds. J Med Chem 53(21):7625-7631
75. Kirmizis A, Bartley SM, Farnham PJ (2003) Identifi cation of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. Mol Cancer Ther 2(1):113-121
76. Kleer CG et al (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA 100(20):11606-11611
77. Klose RJ et al (2006) The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 442(7100):312-316
78. Kohlmaier A et al (2004) A chromosomal memory triggered by Xist regulates histone methylation in X inactivation. PLoS Biol 2(7):E171
79. Kolbel K et al (2009) Type I arginine methyltransferases PRMT1 and PRMT-3 Act distributively. J Biol Chem 284(13):8274-8282
80. Kouzarides T (2007) Chromatin modifi cations and their function. Cell 128(4):693-705
81. Krishnan S, Horowitz S, Trievel RC (2011) Structure and function of histone H3 lysine 9 methyltransferases and demethylases. Chembiochem 12(2):254-263
82. Krivtsov AV, Armstrong SA (2007) MLL translocations, histone modifi cations and leukaemia stem-cell development. Nat Rev Cancer 7(11):823-833
83. Krivtsov AV et al (2008) H3K79 methylation profi les defi ne murine and human MLL-AF4 leukemias. Cancer Cell 14(5):355-368
84. Kubicek S et al (2007) Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell 25(3):473-481
85. Lan F et al (2007) Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression. Nature 448(7154):718-722
86. Lauring J et al (2008) The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. Blood 111(2):856-864
87. Lee SH et al (2005) The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair. Proc Natl Acad Sci USA 102(50): 18075-18080
88. Levine SS et al (2002) The core of the polycomb repressive complex is compositionally and functionally conserved in fl ies and humans. Mol Cell Biol 22(17):6070-6078
89. Li H et al (2006) Molecular basis for site-specifi c read-out of histone H3K4me3 by the BPTF PHD fi nger of NURF. Nature 442(7098):91-95
90. Li Y et al (2009) The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate. J Biol Chem 284(49):34283-34295
91. Li X et al (2010) H4R3 methylation facilitates beta-globin transcription by regulating histone acetyltransferase binding and H3 acetylation. Blood 115(10):2028-2037
92. Lim S et al (2010a) Epigenetic regulation of cancer growth by histone demethylases. Int J Cancer 127(9):1991-1998
93. Lim S et al (2010b) Lysine-specifi c demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 31(3):512-520
94. Liu C et al (2007) The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3. Cancer Res 67(6):2626-2631
95. Liu F et al (2009a) Discovery of a 2, 4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. J Med Chem 52(24):7950-7953
96. Liu G et al (2009b) Genomic amplifi cation and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene 28(50):4491-4500
97. Liu F et al (2010) Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2, 4-diamino-7-aminoalkoxy-quinazolines. J Med Chem 53(15):5844-5857
98. Loyola A et al (2009) The HP1alpha-CAF1-SetDB1-containing complex provides H3K9me1 for Suv39-mediated K9me3 in pericentric heterochromatin. EMBO Rep 10(7):769-775
99. Luo XG et al (2009) Effects of SMYD3 overexpression on transformation, serum dependence, and apoptosis sensitivity in NIH3T3 cells. IUBMB Life 61(6):679-684
100. Majumder S et al (2006) Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability. Prostate 66(12):1292-1301
101. Margueron R et al (2008) Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol Cell 32(4):503-518
102. Maurer-Stroh S et al (2003) The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem Sci 28(2):69-74
103. Min J et al (2003) Structure of the catalytic domain of human DOT1L, a non-SET domain nucleosomal histone methyltransferase. Cell 112(5):711-723
104. Miranda TB et al (2004) PRMT7 is a member of the protein arginine methyltransferase family with a distinct substrate specifi city. J Biol Chem 279(22):22902-22907
105. Morin RD et al (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42(2):181-185
106. Naeem H et al (2007) The activity and stability of the transcriptional coactivator p/CIP/SRC-3 are regulated by CARM1-dependent methylation. Mol Cell Biol 27(1):120-134
107. Ng HH et al (2002a) Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association. Genes Dev 16(12):1518-1527
108. Ng HH et al (2002b) Ubiquitination of histone H2B by Rad6 is required for effi cient Dot1-mediated methylation of histone H3 lysine 79. J Biol Chem 277(38):34655-34657
109. Oda H et al (2009) Monomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development. Mol Cell Biol 29(8):2278-2295
110. Okada Y et al (2005) hDOT1L links histone methylation to leukemogenesis. Cell 121(2):167-178
111. Ooi SK et al (2007) DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448(7154):714-717
112. Pal S et al (2004) Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 24(21):9630-9645
113. Pal S et al (2007) Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma. EMBO J 26(15):3558-3569
114. Pesavento JJ et al (2008) Certain and progressive methylation of histone H4 at lysine 20 during the cell cycle. Mol Cell Biol 28(1):468-486
115. Peters AH et al (2003) Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell 12(6):1577-1589
116. Purandare AV et al (2008) Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1). Bioorg Med Chem Lett 18(15):4438-4441
117. Rao B et al (2005) Dimethylation of histone H3 at lysine 36 demarcates regulatory and nonregulatory chromatin genome-wide. Mol Cell Biol 25(21):9447-9459
118. Rathert P et al (2008) Protein lysine methyltransferase G9a acts on non-histone targets. Nat Chem Biol 4(6):344-346
119. Rea S et al (2000) Regulation of chromatin structure by site-specifi c histone H3 methyltransferases. Nature 406(6796):593-599
120. Richon VM et al (2011) Chemogenetic analysis of human protein methyltransferases. Chem Biol Drug Des 78(2):199-210
121. Rosati R et al (2002) NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15). Blood 99(10):3857-3860
122. Ruthenburg AJ, Allis CD, Wysocka J (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25(1):15-30
123. Sanders SL et al (2004) Methylation of histone H4 lysine 20 controls recruitment of Crb2 to sites of DNA damage. Cell 119(5):603-614
124. Santos-Rosa H et al (2002) Active genes are tri-methylated at K4 of histone H3. Nature 419(6905):407-411
125. Sarma K et al (2008) Ezh2 requires PHF1 to effi ciently catalyze H3 lysine 27 trimethylation in vivo. Mol Cell Biol 28(8):2718-2731
126. Schlesinger Y et al (2007) Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39(2):232-236
127. Schneider R et al (2004) Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 6(1):73-77
128. Schotta G et al (2004) A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev 18(11):1251-1262
129. Schubert HL, Blumenthal RM, Cheng X (2003) Many paths to methyltransfer: a chronicle of convergence. Trends Biochem Sci 28(6):329-335
130. Schulte JH et al (2009) Lysine-specifi c demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res 69(5):2065-2071
131. Schultz DC et al (2002) SETDB1: a novel KAP-1-associated histone H3, lysine 9-specifi c methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-fi nger proteins. Genes Dev 16(8):919-932
132. Shahbazian MD, Zhang K, Grunstein M (2005) Histone H2B ubiquitylation controls processive methylation but not monomethylation by Dot1 and Set1. Mol Cell 19(2):271-277
133. Shi Y, Whetstine JR (2007) Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 25(1):1-14
134. Shi X et al (2006) ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442(7098):96-99
135. Shia WJ et al (2012) PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential. Blood 119(21):4953-4962
136. Shilatifard A (2008) Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. Curr Opin Cell Biol 20(3):341-348
137. Simon JA, Lange CA (2008) Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 647(1-2):21-29
138. Sims RJ 3rd, Reinberg D (2006) Histone H3 Lys 4 methylation: caught in a bind Genes Dev 20(20):2779-2786
139. Singer MS et al (1998) Identifi cation of high-copy disruptors of telomeric silencing in Saccharomyces cerevisiae. Genetics 150(2):613-632
140. Slany RK (2009) The molecular biology of mixed lineage leukemia. Haematologica 94(7): 984-993
141. Sneeringer CJ et al (2010) Coordinated activities of wild-type plus mutant EZH2 drive tumorassociated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. Proc Natl Acad Sci USA 107(49):20980-20985
142. Squazzo SL et al (2006) Suz12 binds to silenced regions of the genome in a cell-type-specifi c manner. Genome Res 16(7):890-900
143. Stec I et al (1998) WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum Mol Genet 7(7):1071-1082
144. Steger DJ et al (2008) DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol 28(8):2825-2839
145. Strahl BD et al (1999) Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc Natl Acad Sci USA 96(26): 14967-14972
146. Tachibana M et al (2002) G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 16(14):1779-1791
147. Tachibana M et al (2005) Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev 19(7):815-826
148. Tan X et al (2006) SmyD1, a histone methyltransferase, is required for myofi bril organization and muscle contraction in zebrafi sh embryos. Proc Natl Acad Sci USA 103(8):2713-2718
149. Tang J, Kao PN, Herschman HR (2000) Protein-arginine methyltransferase I, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3. J Biol Chem 275(26):19866-19876
150. Therrien E et al (2009) 1, 2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1). Bioorg Med Chem Lett 19(23):6725-6732
151. Troffer-Charlier N et al (2007) Functional insights from structures of coactivator-associated arginine methyltransferase 1 domains. EMBO J 26(20):4391-4401
152. Tryndyak VP, Kovalchuk O, Pogribny IP (2006) Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins. Cancer Biol Ther 5(1):65-70
153. Van Den Broeck A et al (2008) Loss of histone H4K20 trimethylation occurs in preneoplasia and infl uences prognosis of non-small cell lung cancer. Clin Cancer Res 14(22):7237-7245
154. van Haaften G et al (2009) Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet 41(5):521-523
155. van Leeuwen F, Gafken PR, Gottschling DE (2002) Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell 109(6):745-756
156. Varambally S et al (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419(6907):624-629
157. Vedadi M et al (2011) A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat Chem Biol 7(8):566-574
158. Wagschal A et al (2008) G9a histone methyltransferase contributes to imprinting in the mouse placenta. Mol Cell Biol 28(3):1104-1113
159. Wan H et al (2009) Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)-Hit to Lead studies. Bioorg Med Chem Lett 19(17): 5063-5066
160. Wang H et al (2003) mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression. Mol Cell 12(2):475-487
161. Wang GG et al (2007) NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 9(7):804-812
162. Wang SZ et al (2008a) Knockdown of SMYD3 by RNA interference inhibits cervical carcinoma cell growth and invasion in vitro. BMB Rep 41(4):294-299
163. Wang L, Pal S, Sif S (2008b) Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells. Mol Cell Biol 28(20):6262-6277
164. Wang P et al (2009) Global analysis of H3K4 methylation defi nes MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II. Mol Cell Biol 29(22):6074-6085
165. Watanabe H et al (2008) Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells. Cancer Cell Int 8:15
166. Weidinger G (1995) Pharmacokinetic and pharmacodynamic properties and therapeutic use of bunazosin in hypertension. A review. Arzneimittelforschung 45(11):1166-1171
167. Wigle TJ et al (2010) Screening for inhibitors of low-affi nity epigenetic peptide-protein interactions: an AlphaScreen-based assay for antagonists of methyl-lysine binding proteins. J Biomol Screen 15(1):62-71
168. Wu H et al (2010) Structural biology of human H3K9 methyltransferases. PLoS One 5(1):e8570
169. Wysocka J et al (2006) A PHD fi nger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442(7098):86-90
170. Xiang Y et al (2007) JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc Natl Acad Sci USA 104(49):19226-19231
171. Xiao B et al (2005) Specifi city and mechanism of the histone methyltransferase Pr-Set7. Genes Dev 19(12):1444-1454
172. Xin Z et al (2003) Role of histone methyltransferase G9a in CpG methylation of the Prader-Willi syndrome imprinting center. J Biol Chem 278(17):14996-15000
173. Xu W et al (2004) A methylation-mediator complex in hormone signaling. Genes Dev 18(2):144-156
174. Xu C et al (2010) Binding of different histone marks differentially regulates the activity and specifi city of polycomb repressive complex 2 (PRC2). Proc Natl Acad Sci USA 107(45):19266-19271
175. Yang ZQ et al (2000) Identifi cation of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res 60(17):4735-4739
176. Yang H et al (2008) Preferential dimethylation of histone H4 lysine 20 by Suv4-20. J Biol Chem 283(18):12085-12092
177. Yap DB et al (2011) Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 117(8):2451-2459
178. Yuan W et al (2009) Heterogeneous nuclear ribonucleoprotein L Is a subunit of human KMT3a/Set2 complex required for H3 Lys-36 trimethylation activity in vivo. J Biol Chem 284(23):15701-15707
179. Yue WW et al (2007) Insights into histone code syntax from structural and biochemical studies of CARM1 methyltransferase. EMBO J 26(20):4402-4412
180. Zhang X, Bruice TC (2007) Histone lysine methyltransferase SET7/9: formation of a water channel precedes each methyl transfer. Biochemistry 46(51):14838-14844
181. Zhang X, Bruice TC (2008) Enzymatic mechanism and product specifi city of SET-domain protein lysine methyltransferases. Proc Natl Acad Sci USA 105(15):5728-5732
182. Zhang X, Cheng X (2003) Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. Structure 11(5):509-520
183. Zhang X, Zhou L, Cheng X (2000) Crystal structure of the conserved core of protein arginine methyltransferase PRMT3. EMBO J 19(14):3509-3519
184. Zhao Q et al (2009) PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing. Nat Struct Mol Biol 16(3):304-311